Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Verni Aesthetics is a South Korean biotech startup founded in 2019 by a team of dermatologists specializing in aesthetic medicine. The company focuses on developing innovative non-surgical treatments for fat reduction and anti-aging. Its lead candidate, MRC101 (also known as Miracle Injection), is a fat decomposition injection currently in Phase 2 clinical trials for the reduction of localized fat, such as submental fat. In November 2024, the company entered into a strategic partnership with Huons Biopharma, which secured the commercialization and manufacturing rights for MRC101. Verni Aesthetics is also advancing a pipeline of next-generation aesthetic products, including a human-derived collagen booster.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Verni Aesthetics.